Linking ALS mutations to the disruption of the MHC-II pathway
Proc Natl Acad Sci U S A
.
2023 Oct 24;120(43):e2315240120.
doi: 10.1073/pnas.2315240120.
Epub 2023 Oct 11.
Authors
Zhe Zhang
1
,
Shuying Sun
1
2
3
Affiliations
1
Department of Physiology and Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
2
The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
3
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
PMID:
37819987
PMCID:
PMC10614208
DOI:
10.1073/pnas.2315240120
No abstract available
Publication types
Comment
MeSH terms
Antigen Presentation*
Genes, MHC Class II
Histocompatibility Antigens Class II* / immunology
Mutation
Substances
Histocompatibility Antigens Class II
Grants and funding
R01 AG078948/AG/NIA NIH HHS/United States
RF1 NS113820/NS/NINDS NIH HHS/United States
RF1 NS127925/NS/NINDS NIH HHS/United States